SEC Filings

Filing date	Form	Description	View
11/09/16	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0001104659-16-155621.pdf 0001104659-16-155621.rtf 0001104659-16-155621.xls EX-101.INS - XBRL INSTANCE DOCUMENT
11/08/16	8-K	Report of unscheduled material events or corporate event	View HTML 0001144204-16-132419.pdf 0001144204-16-132419.rtf 0001144204-16-132419.xls
11/02/16	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-16-154218.pdf 0001104659-16-154218.rtf 0001104659-16-154218.xls
10/31/16	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	View HTML 0001047469-16-016386.pdf 0001047469-16-016386.rtf 0001047469-16-016386.xls
10/31/16	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	View HTML 0001047469-16-016388.pdf 0001047469-16-016388.rtf 0001047469-16-016388.xls
10/28/16	FWP	FWP	View HTML 0001104659-16-152698.pdf 0001104659-16-152698.rtf 0001104659-16-152698.xls
10/26/16	S-3ASR	S-3ASR	View HTML 0001047469-16-016307.pdf 0001047469-16-016307.rtf 0001047469-16-016307.xls
10/26/16	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	View HTML 0001047469-16-016313.pdf 0001047469-16-016313.rtf 0001047469-16-016313.xls
10/26/16	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	View HTML 0001047469-16-016312.pdf 0001047469-16-016312.rtf 0001047469-16-016312.xls
10/25/16	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-16-151805.pdf 0001104659-16-151805.rtf 0001104659-16-151805.xls

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.